03.04.24|CTechLeveraging AI and machine learning, Nucleai analyzes pathology images and spatial data at the cellular and tissue levels. The proprietary technology extracts detailed patterns and features from medical images, offering insights into the tumor microenvironment, cellular morphology, and spatial relationships between different cell types
26.10.23|James SpiroNucleai helped its global customers and investors understand the magnitude of October 7 by comparing it to 9/11 in the U.S.
22.03.22|Meir OrbachThe technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs
02.01.22|Yafit OvadiaNucleai is looking at the way cells interplay and are interspersed within human tissue to develop precision medicine solutions
07.07.20|Meir OrbachNucleai’s software uses computer vision and machine learning algorithms to predict the progress of cancerous tumors as well as the patient’s immune system response in order to determine the most efficient treatment
05.03.18|CTechIsrael wants to lure U.S. scientists with $100 thousand grants. Barclays ends partnership with Ness Technologies